Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Value-Based Care
ASCO’s Annual Report: Major Advances in Oncology and the Challenge of Value-Based Care
By
Eileen Koutnik-Fotopoulos
Health Policy
,
Value-Based Care
,
Policies & Guidelines
April 2015, Vol 6, No 3
Significant gains in cancer research and prevention have led to longer survival, improved quality of life, and decreased disease burden. The 2015 annual report on “Clinical Cancer Advances” from the American Society of Clinical Oncology (ASCO) outlines the biggest advances made in oncology, and for the first time designates one cancer as the Advance of the Year, as well as emphasizing the ongoing challenge of value-based care.
Read Article
NCCN Panel Addresses Value-Based Care in Oncology
By
Wayne Kuznar
Economics & Value
,
Economics of Cancer Care
,
Value-Based Care
April 2015, Vol 6, No 3
Hollywood, FL—Value-based decision-making at the bedside can be fraught with obstacles, with no clear agreement on what constitutes value, and for whom. In addition, the myriad insurance plans preclude uniform treatment strategies, despite clinical pathways and guidelines intended to reduce variation in care. Finally, value is becoming more difficult to achieve in oncology as each benefit becomes more expensive, with the cost of new therapies outpacing inflation.
Read Article
Logistic Toxicity: Obstacles to the Efficient Delivery of Cancer Care
By
Barry D. Brooks, MD
Value-Based Care
,
VBCC Perspectives
October 2014, Vol 5 , No 8
The Merriam-Webster dictionary defines “logistics” as the things that must be done to plan and organize a complicated activity that involves many people. The modern delivery of cancer care precisely parallels this definition.
Read Article
Oncologists Can Become Value-Based Providers Using Evidence to Guide Patient Care
By
Wayne Kuznar
Value in Oncology
,
Value-Based Care
September 2014, Vol 5, No 7
Chicago, IL—Oncologists should become value-based providers by eliminating unnecessary tests, prescribing cheaper alternatives when therapeutic equivalents exist, and keep calling for payment reform, said Ezekiel J. Emanuel, MD, PhD, Chair, Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, at the 2014 American Society of Clinical Oncology meeting, during a session on defining value from different stakeholder perspectives.
Read Article
ALTTO: Dual Anti-HER2 Adjuvant Therapy No Better than Trastuzumab Alone
By
Phoebe Starr
Breast Cancer
,
Personalized Medicine
,
Value-Based Care
August 2014, Vol 5, No 6
The addition of lapatinib (Tykerb) to trastuzumab (Herceptin) to create dual HER2 blockade was no better than trastuzumab alone in the adjuvant treatment of patients with HER2 breast cancer in the global phase 3 ALTTO (Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) trial, reported Martine J. Piccart-Gebhart, MD, PhD, Chair, Breast International Group, Brussels, Belgium, at a plenary session at the 2014 American Society of Clinical Oncology (ASCO) meeting.
Read Article
Shifts to Value-Based Care and Payment Models Are Improving Quality of Care
By
Wayne Kuznar
Economics & Value
,
Reimbursement
,
Value-Based Care
August 2014, Vol 5, No 6
Blue Cross Blue Shield (BCBS) is implementing value-based care and payment models across the country to reward quality and improve outcomes, and these are amounting to billions of dollars in cost-savings and reduced hospitalizations.
Read Article
Promising New Therapies in the Breast Cancer Pipeline
By
Phoebe Starr
Value-Based Care
,
VBCC Perspectives
March 2014, Vol 5, No 2
San Antonio, TX—Many new drugs are currently in development for the treatment of patients with breast cancer. The following is a selection of drugs featured at the 2013 San Antonio Breast Cancer Symposium.
Read Article
Considering Prophylactic Salpingo-Oophorectomy in Women with BRCA Mutations
By
Jonathan S. Berek, MD, MMS
;
Allison W. Kurian, MD, MSc
Value-Based Care
,
VBCC Perspectives
March 2014, Vol 5, No 2
The study “Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation” that was recently published in the Journal of Clinical Oncology (Finch AP, et al. 2014 February 24 [Epub ahead of print]) provides an update of previous work by the same investigators on a similar population.
Read Article
Ten Steps to Achieving Value-Based Care at the Mayo Clinic
By
Rosemary Frei, MSc
Value in Oncology
,
Value-Based Care
November 2013, Vol 4, No 9
Phoenix, AZ—The staff at the Mayo Clinic are working to “bend the cost curve” and optimize resource utilization efficiency while continuing to provide high-quality care to their large population of patients, said Kari Bunkers, MD, Chief Medical Information Officer, Mayo Clinic Health System, and Medical Director, Mayo Clinic Office of Population Health Management (OPHM) at the American Medical Group Association 2013 Institute for Quality Leadership conference.
Read Article
Value-Based Care Will Change the Face of Medicine
Economics & Value
,
Value Propositions
,
Value-Based Care
,
Value Peer-spectives
October 2013, Vol 4, No 8
In a recent guest blog on the
Harvard Business Review
website, Toby Cosgrove, MD, President and CEO of the Cleveland Clinic in Ohio, suggested that value-based care represents a life-saving “breakthrough,” not unlike penicillin or decoding the human genome, by focusing on lowering costs and improving quality of care and outcomes as its main goals.
Read Article
Page 9 of 12
3
4
5
6
7
8
9
10
11
12
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma